EUVIMEDEUVIMED entdecken
VergleichsstudieValidierungsstudie

Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™

Wafa Masri, Wajed Abarah, Mustapha Taileb, Anh Cung, Mourad Bendaoud

Annales de Biologie Clinique · 2026-06 · 84 (3) · 245-252

DOI: 10.1684/abc.2026.2044 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Annales de Biologie Clinique, 2026-06. Verfasst von Wafa Masri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Grand Hôpital de l'Est Francilien, Meaux, France. Hauptthemen laut MEDLINE: Paraproteinemias, Immunoglobulin kappa-Chains, Immunoglobulin lambda-Chains, Immunoglobulin Light Chains.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Serum free light chains (FLC) are key biomarkers for the diagnosis and monitoring of plasma cell dyscrasias. Current International Myeloma Working Group (IMWG) recommendations are based on Freelite™ assays. This study aimed to evaluate the analytical performance and clinical concordance of Diazyme κ and λ FLC assays on the Roche Cobas® platform in comparison with Freelite™. A total of 660 serum samples from patients with multiple myeloma, MGUS/smoldering myeloma, Waldenström macroglobulinemia, AL amyloidosis, and other gammopathies were analyzed. Precision, reference intervals, and method comparison were assessed according to CLSI EP05-A3 and EP09-A3 guidelines. Statistical analyses included Passing-Bablok regression, Bland-Altman analysis, Pearson correlation, and evaluation of clinical concordance. Within-run and total imprecision showed coefficients of variation ≤ 6%. Reference intervals for the κ/λ ratio were 0.22-2.25 in healthy individuals and 0.30-2.75 in patients with renal insufficiency. Method comparison demonstrated strong agreement with Freelite™ for κ (y = 0.95x + 0.34, R² = 0.96), λ (y = 0.90x + 4.1, R² = 0.91), and κ/λ ratio (r = 0.92). Overall clinical concordance was 96%, with discrepancies mainly observed near decision thresholds. Diazyme κ and λ FLC assays on the Cobas® platform show excellent analytical performance and high clinical concordance with Freelite™, supporting their use in routine laboratory practice, with applicability to IMWG-based interpretation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParaproteinemiasImmunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Light ChainsHumansReproducibility of ResultsReference ValuesMultiple MyelomaImmunoassayWaldenstrom Macroglobulinemia

Stichwörter der Autor:innen

analytical validationfree light chainsimmunoassaymethod comparisonplasma cell dyscrasias

Substanzen

Immunoglobulin kappa-ChainsImmunoglobulin lambda-ChainsImmunoglobulin Light Chains

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Grand Hôpital de l'Est Francilien, Meaux, France.
  • Department of Clinical Hematology, Grand Hôpital de l'Est Francilien, Meaux, France.

Zitieren

APA

Masri, W., Abarah, W., Taileb, M., Cung, A., & Bendaoud, M. (2026). Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™. Annales de Biologie Clinique, 84(3), 245-252. https://doi.org/10.1684/abc.2026.2044

Vancouver

Masri W, Abarah W, Taileb M, Cung A, Bendaoud M. Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™. Annales de Biologie Clinique. 2026;84(3):245-252. doi:10.1684/abc.2026.2044

BibTeX
@article{Masri2026,
  author = {Masri, Wafa and Abarah, Wajed and Taileb, Mustapha and Cung, Anh and Bendaoud, Mourad},
  title = {Analytical validation and clinical concordance of Diazyme free light chain assays on the Cobas® platform compared with Freelite™},
  journal = {Annales de Biologie Clinique},
  year = {2026},
  volume = {84},
  number = {3},
  pages = {245--252},
  doi = {10.1684/abc.2026.2044}
}
Kostenlos starten →